Anthony V. Minniti, BScPharm, RPh FACA’s Post

Shocking, though I don't know why I'm shocked, news from Scott Van Voorhis about the Massachusetts Office of the Inspector General reaching out urgently to the Massachusetts Legislature to place the Cannabis Control Commission in receivership. From the IG's letter: "The OIG urges the legislative leadership to take immediate action to statutorily authorize the appointment of, and appoint, a receiver with the authority to manage the day-to-day operations of the CCC. The receiver should be expressly authorized (1) to carry out the daily administrative functions of the CCC and (2) to carry out said functions notwithstanding any assertion of authority by the chair, acting chair, or commissioners under Chapter 76." The #cannabisindustry in Massachusetts is out of its infancy and as such it needs a regulatory agency with the bandwidth, infrastructure, and expertise to oversee it. As personalities and intra-agency power struggles suck all the oxygen out of the air, critical issues are left unaddressed. (product testing, delivery regulations, synthetic cannabis) The cannabis industry is complex, hypercompetitive, and volatile. Creating a stable industry and surpassing the unregulated market requires clear leadership, institutional transparency, and reliable, consistent regulatory practices. We haven't seen that of late from the CCC. Receivership might not be the only fix, but it's clear that something drastic needs to change soon. #cannabispolicy #regulatorypolicy #drugreform #cannabis https://lnkd.in/epH5BTBy

ICYMI: Dope piece in Green Market Report featuring Marino. client International Cannabis Bar Association (INCBA) on their recent #CannabisLawInstitute event in #Chicago! At the heart of every evolving industry is a need for clarity, especially when it comes to #cannabis and #federalrescheduling. That's why the INCBA is leading the charge on navigating the legal uncertainties surrounding cannabis reform. 🌱⚖️ Recently at the INCBA conference, some of the top legal minds gathered to discuss the implications of potential #rescheduling – and the message is clear: there’s still a long road ahead. From challenges in banking access to concerns about #DEA enforcement, this was a deep dive into the future of the #cannabisindustry. While many see rescheduling as a step forward, the conversation highlighted a bigger need for well-defined laws and guidance to truly unlock the market's potential. "The federal marijuana rescheduling process is far from complete, and major questions over the timeline still loom large over the U.S. cannabis industry. That was the sentiment from a bevy of legal experts and industry insiders during several panels at a gathering of the International Cannabis Bar Association in Chicago last week." #cannabis #cannabislaw #cannabisbusiness #cannabisindustry #cannabisreform #cannabiscommunity #MarinoCannabis Jason Horst Nastasia M. #cannabispr

Cannabis Reform Advocates Push Trump for Federal Legalization Two major cannabis reform groups, the Marijuana Policy Project (MPP) and NORML, have urged President-elect Donald Trump to prioritize federal cannabis reforms during his upcoming term. In a detailed memo, the organizations outlined key proposals, including ending federal cannabis prohibition to allow states to set their own policies, protecting Second Amendment rights for cannabis consumers, ensuring banking access for cannabis businesses, and expanding clemency for individuals with federal cannabis-related convictions. They also advocated for removing barriers to cannabis research, restoring access to federal housing and employment for cannabis users, and permitting Washington, D.C., to establish an adult-use cannabis sales framework. Highlighting widespread public support for legalization, the memo cited the STATES Act 2.0 as a roadmap for sensible federal policy, which includes legalizing interstate commerce and normalizing tax regulations for the industry. The groups argued that ending prohibition would reduce federal overreach and empower states while ensuring safety and equity in cannabis regulation. Both MPP and NORML emphasized Trump’s opportunity to lead on a national level by modernizing outdated policies and advancing liberty through cannabis reform. #CannabisReform #EndCannabisProhibition #FederalCannabisPolicy #CannabisLegalization #CannabisRights

🌿 Cannabis Rescheduling FAQ: What Now? 🌿 The DEA’s proposal to reclassify cannabis from Schedule I to Schedule III under the Controlled Substances Act (CSA) is a significant development, though the process is still ongoing and could face various challenges before finalization. While this move aligns with the Department of Health and Human Services’ (HHS) recommendations, it does not legalize cannabis federally. 🚀 Jonathan Havens, managing partner at Saul Ewing, emphasizes the importance of this potential change, highlighting it as the most significant federal reform since the CSA’s enactment. He notes that the rulemaking process is swift by Washington standards but still complex, with a public comment period and potential legal challenges expected. 💼 Rescheduling cannabis to Schedule III would alleviate some restrictions, notably removing the burdensome Internal Revenue Code Section 280E, allowing state-legal cannabis companies to take standard business tax deductions. However, it won’t fully integrate cannabis into the legal framework enjoyed by other industries like alcohol and tobacco. ⚖️ Legal experts like Sander Zagzebski caution that Schedule III reclassification won’t immediately normalize cannabis business operations. The industry would still face regulatory challenges, and banking legislation such as the SAFER Banking Act remains crucial. While rescheduling marks progress, comprehensive federal legalization and regulatory clarity are still needed. 📈 As a Cannabis Franchise Broker with Cannabis10X, I see this as a pivotal moment. We have numerous red-hot opportunities in the cannabis market. Reach out to me directly to capitalize on this rapidly growing sector and secure your investment in the future of cannabis. 🌱 #CannabisIndustry #CannabisInvestment #CannabisRescheduling #CannabisBusiness #CannabisReform Orginal art by: HaraLine Cannabis10X 5

🌿 Cannabis Rescheduling FAQ: What Now? 🌿 The DEA’s proposal to reclassify cannabis from Schedule I to Schedule III under the Controlled Substances Act (CSA) is a significant development, though the process is still ongoing and could face various challenges before finalization. While this move aligns with the Department of Health and Human Services’ (HHS) recommendations, it does not legalize cannabis federally. 🚀 Jonathan Havens, managing partner at Saul Ewing, emphasizes the importance of this potential change, highlighting it as the most significant federal reform since the CSA’s enactment. He notes that the rulemaking process is swift by Washington standards but still complex, with a public comment period and potential legal challenges expected. 💼 Rescheduling cannabis to Schedule III would alleviate some restrictions, notably removing the burdensome Internal Revenue Code Section 280E, allowing state-legal cannabis companies to take standard business tax deductions. However, it won’t fully integrate cannabis into the legal framework enjoyed by other industries like alcohol and tobacco. ⚖️ Legal experts like Sander Zagzebski caution that Schedule III reclassification won’t immediately normalize cannabis business operations. The industry would still face regulatory challenges, and banking legislation such as the SAFER Banking Act remains crucial. While rescheduling marks progress, comprehensive federal legalization and regulatory clarity are still needed. 📈 As a Cannabis Franchise Broker with Cannabis10X, I see this as a pivotal moment. We have numerous red-hot opportunities in the cannabis market. Reach out to me directly to capitalize on this rapidly growing sector and secure your investment in the future of cannabis. 🌱 #CannabisIndustry #CannabisInvestment #CannabisRescheduling #CannabisBusiness #CannabisReform Orginal art by: HaraLine

Cannabis companies have doubled their lobbying efforts in Washington, D.C., spending nearly $4 million in the first half of 2024, driven by growing interest in federal cannabis legislation and potential regulatory changes. This surge reflects a broader industry shift, with cannabis increasingly seen as a bipartisan issue and attracting attention from other sectors like tobacco and alcohol. Click below to learn more about what this means for the industry 👇 https://lnkd.in/eaY333PE

California's Cannabis Industry: Is the Golden State Losing its Green? #cannabisindustry #california California, once the undisputed king of cannabis, is facing a harsh new reality: its legal cannabis market is struggling. Despite high hopes and initial success, the industry is grappling with a multitude of challenges that threaten its future, and its crown is at risk. In fact, Michigan surpassed California as the largest cannabis market by sales volume in 2023, signaling a potential shift in the industry landscape. Key Challenges: Flourishing Illicit Market: A persistent illegal market continues to thrive, estimated to be twice the size of the legal one. This illicit trade undercuts legal businesses by offering cheaper products that bypass taxes and regulations. Declining Sales: The legal cannabis market in California is experiencing a concerning trend of declining sales. Projections indicate a 3.4% decrease in 2024 compared to the previous year. Regulatory and Enforcement Hurdles: The state faces significant challenges in effectively regulating the industry and enforcing compliance [source]. Product Safety Concerns: Recent investigations have revealed contaminated cannabis products within the legal market, raising serious concerns about consumer safety. High Taxes and Stifling Regulations: Legal cannabis businesses in California are burdened with high taxes and strict regulations, making it difficult to compete with the illicit market. Limited Access: Limited retail access remains a significant barrier. With a majority of cities and counties prohibiting cannabis businesses, many residents lack convenient access to legal dispensaries. The Path Forward: Addressing these challenges requires a multi-pronged approach. streamlining regulations, and reducing the tax burden on legal businesses are crucial steps. Furthermore, restoring consumer confidence through rigorous product testing and transparency is essential. The California cannabis industry stands at a crossroads. The choices made today will determine whether it reclaims its dominance or fades in the face of growing competition and internal challenges. What are your thoughts on the future of California's cannabis industry? Share your insights in the comments below. #cannabiscommunity #legalization #regulation #markettrends #consumerprotection

The cannabis market is heating up just in time for the election. #KamalaHarris has officially rolled out her plan to federally legalize cannabis, setting the stage for what could be a defining moment for the industry. Now, all eyes are on #Trump to see how he follows up on his recent pro adult-use comments in Florida. The political winds are shifting, and as we anticipated, cannabis reform is becoming a center-stage issue right before the election. This momentum isn't just about policy—it's about new market opportunities opening up across the U.S. For investors, the timing couldn't be better. With federal legalization on the table, we could be witnessing the dawn of a new era for cannabis capital markets, regulatory clarity, and access to institutional financing. The question now is: How will both sides position themselves? Will we see a race to champion cannabis reform? Or will the market continue to be shaped by uncertainty? One thing is certain: those prepared to ride the wave of reform will reap the rewards. 🌱📈 #CannabisIndustry #CannabisInvestment #CannabisReform #CapitalMarkets #SAFEAct #Election2024 KEY Investment Partners Pete Karabas Jordan Youkilis Clayton Skulski Blaine Rhoden US Cannabis Council David Culver

Big news for the cannabis industry: Earlier this week, the DEA announced its plan to reschedule cannabis from Schedule I to Schedule III under the Controlled Substances Act. This historic change will reshape the market dynamics and legal framework of the cannabis industry, and now is the time to start thinking about how you can adapt your business strategy to take advantage of the new possibilities and avoid the pitfalls. Check out Withum's latest cannabis article for more information. #Withum #Cannabis #280E